Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1700 of 3546 entries
View as:

A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward

Phase: N/A Priority: Normal
NCT ID: NCT00605241 Org: User:
Start: 02/25/08 End: 03/20/09 Due: 03/20/10

A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02727283 Org: User:
Start: 11/26/15 End: 03/18/16 Due: 03/18/17

To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03415243 Org: User:
Start: 03/01/18 End: 03/29/18 Due: 03/29/19

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01227889 Org: User:
Start: 12/23/10 End: 09/16/16 Due: 09/16/17

A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01267071 Org: User:
Start: 06/14/10 End: 09/01/10 Due: 09/01/11

Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02513654 Org: User:
Start: 09/06/15 End: 11/11/15 Due: 11/11/16

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00698568 Org: User:
Start: 10/31/96 End: 04/30/99 Due: 04/30/00

Lamotrigine Phase III Study in Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01602510 Org: User:
Start: 08/31/12 End: 12/31/15 Due: 12/31/16

A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)

Phase: N/A Priority: Normal
NCT ID: NCT02424539 Org: User:
Start: 09/30/15 End: 10/25/17 Due: 10/25/18

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00524303 Org: User:
Start: 08/31/07 End: 08/31/15 Due: 08/31/16

Effect of GSK1160724 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00555022 Org: User:
Start: 12/12/07 End: 04/07/08 Due: 04/07/09

LRRK2 Mutation and Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01424475 Org: User:
Start: 08/11/11 End: 01/12/15 Due: 01/12/16

GSK BHR Study (Sont)

Phase: N/A Priority: Normal
NCT ID: NCT00920543 Org: User:
Start: 02/28/03 End: 10/31/04 Due: 10/31/05

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT05087056 Org: User:
Start: 12/29/21 End: 02/26/27 Due: 02/26/28

Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT04971590 Org: User:
Start: 09/14/21 End: 10/31/24 Due: 10/31/25

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05089630 Org: User:
Start: 10/14/21 End: 04/02/25 Due: 04/02/26

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT01165229 Org: User:
Start: 08/02/10 End: 07/24/15 Due: 07/24/16

Study to Evaluate an Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00540228 Org: User:
Start: 10/05/07 End: 05/08/08 Due: 05/08/09

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00504816 Org: User:
Start: 04/30/07 End: 04/30/08 Due: 04/30/09

Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT01884675 Org: User:
Start: 09/30/13 End: 03/31/15 Due: 03/31/16

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT00697242 Org: User:
Start: 01/31/94 End: 11/30/95 Due: 11/30/96

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT01733758 Org: User:
Start: 02/28/13 End: 02/28/15 Due: 02/28/16

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

Phase: N/A Priority: Normal
NCT ID: NCT02207413 Org: User:
Start: 08/18/14 End: 04/18/15 Due: 04/18/16

Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01934101 Org: User:
Start: 08/12/13 End: 05/28/14 Due: 05/28/15

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Phase: N/A Priority: Normal
NCT ID: NCT00612456 Org: User:
Start: 03/05/08 End: 06/17/09 Due: 06/17/10